Benzinga · Sep 8, 2026
Milestone Scientific Files Prospectus To Offer Securities Up To $45M
-SEC Filing
ML
AMEX · MLSS
Milestone Scientific Inc.
Healthcare · Medical - Instruments & Supplies
$0.44
Down-$0.02 (-4.68%)
Updated Sep 14, 2026, 7:15 PM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 28.42M
- P/E ratio
- -4.46
- Dividend yield
- 0.00%
- 52-week range
- $0.25 – $0.58
- Volume
- 38.79K
- Avg. volume
- 1.16M
Price performance
MLSS price history
1M range · 19 trading sessions · Daily adjusted prices
MLSS closed at $0.44 after 19 trading sessions, down 9.02% for the selected period.
- Last close
- $0.44
- Period change
- -9.02%
- Period low
- $0.42
- Period high
- $0.54
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.4425 | $0.445 | $0.4282 | $0.444 | 38.79K |
| Sep 10, 2026 | $0.404 | $0.4493 | $0.403 | $0.4341 | 142.04K |
| Sep 9, 2026 | $0.4488 | $0.4649 | $0.3998 | $0.418 | 111.29K |
| Sep 8, 2026 | $0.465 | $0.465 | $0.438 | $0.44 | 88.36K |
| Sep 4, 2026 | $0.451 | $0.47 | $0.451 | $0.4692 | 37.8K |
| Sep 3, 2026 | $0.451 | $0.485 | $0.4501 | $0.4689 | 44.08K |
| Sep 2, 2026 | $0.4719 | $0.4887 | $0.4639 | $0.4639 | 87.7K |
| Sep 1, 2026 | $0.4763 | $0.479 | $0.45 | $0.458 | 69.47K |
| Aug 31, 2026 | $0.49 | $0.49 | $0.4768 | $0.4768 | 27.56K |
| Aug 28, 2026 | $0.4935 | $0.5116 | $0.4933 | $0.502 | 29.49K |
| Aug 27, 2026 | $0.54 | $0.54 | $0.4891 | $0.505 | 140.77K |
| Aug 26, 2026 | $0.50 | $0.5394 | $0.48 | $0.5394 | 333.15K |
| Aug 25, 2026 | $0.473 | $0.49 | $0.47 | $0.485 | 55.18K |
| Aug 24, 2026 | $0.4814 | $0.495 | $0.4701 | $0.473 | 21.62K |
| Aug 21, 2026 | $0.48 | $0.49 | $0.47 | $0.4808 | 91.05K |
| Aug 20, 2026 | $0.47 | $0.477 | $0.44 | $0.4703 | 42.88K |
| Aug 19, 2026 | $0.481 | $0.4999 | $0.461 | $0.4701 | 77.54K |
| Aug 18, 2026 | $0.485 | $0.5032 | $0.4612 | $0.493 | 131.71K |
| Aug 17, 2026 | $0.49 | $0.49 | $0.4565 | $0.488 | 423.85K |
Latest MLSS news
The latest Smart Investors Daily articles mentioning MLSS.
Stock researchCompany · Overview
MLSS research
Overview
Company profile and research snapshot.
Company profile
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $4.00
- Implied upside
- —
- Analysts
- 8
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 20, 2025 | Benchmark | Speculative Buy | — |
| Nov 20, 2024 | Benchmark | Speculative Buy | — |
| Oct 10, 2024 | Benchmark | Speculative Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 26, 2026
Milestone Scientific Directors Convert $465K Loans Into Equity, Eliminating Debt And Achieving Debt‑Free Balance Sheet
Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that three members of its Board of Directors have converted
SeekingAlpha · Aug 14, 2026
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call August 14, 2026 8:30 AM EDTCompany ParticipantsEric Hines - CEO, President & DirectorKeisha...
Benzinga · Aug 14, 2026
Conference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M Est
Milestone Scientific (AMEX:MLSS) affirms FY2026 sales outlook from $9.800 million-$10.200 million to $9.800 million-$10.200 million vs $9.910 million estimate.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
